地點： New York， NY
介紹
添加了以下演示文稿，希望它能説明其他有興趣瞭解更多關於 ECD 的醫生和研究人員。 ECDGA 感謝醫學界為改善對 ECD 患者的護理所做的努力和貢獻。
| Presenter | Presentation Slides |
| Ankush Bhatia, MD | Single-agent dabrafenib for BRAFV600E-mutated histiocytosis |
| Riccardo Biavasco, MD | BRAFV600E expression in hematopoietic progenitors leads to myeloid skewing and histiocytosis |
| Pascale Chasseur, MD | A cytologic diagnosis of BRAFV600E Erdheim-Chester disease on pericardial fluid |
| Marina Ferrarini, MD | 3-D culture of BRAF and KRAS-mutated Erdheim-Chester disease tissues: impact of kinase inhibitors |
| Aaron Goodman, MD | Genomics of Erdheim Chester Disease: Implications for Precision Treatment with Targeted Therapy |
| Gaurav Goyal, MBBS | Efficacy of Biologic Agents in the Treatment of Erdheim-Chester Disease |
| Gaurav Goyal, MBBS | Increased prevalence of myeloid neoplasms in patients with Erdheim-Chester disease |
| Julien Haroche, MD, PhD | BRAF V600E mutation is associated with a cardiac and neurological phenotype in Erdheim-Chester disease: results from a 165-patient cohort |
| Filip Janku, MD, PhD | Clinical molecular profiling of archival tumor tissue and cell-free DNA from patients with Erdheim-Chester disease |
| Augusto Vaglio, MD | Renal and ureteral involvement in Erdheim-Chester disease: analysis of a single centre cohort |
照片 – 接待處
照片 – 醫療會議
以下照片於 10 月 27 日在紐約州紐約市舉行的 ECD 醫學研討會期間拍攝。感謝所有參與者和演講者在本次活動中給予的充實和啟發性體驗。請於 2018 年 11 月 15 日在奧蘭多再次加入我們！也請查看 患者和家庭聚會頁面 以獲取更多資訊。
地點： New York， NY
